Bought
Maintained
Sold
Other funds holding AMGN
BIT
BFA
Baird's AMGN Position: Q1 2015 in Review
Baird increased its Amgen (AMGN) stake by 29% in Q1 2015, buying an estimated $4M and bringing the position to 113,732 shares worth $18.2M. The position accounts for 0.19% of the portfolio, ranked #159.
Baird first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.
- Baird held 113,732 shares of Amgen worth $18.2M as of Q1 2015.
- Baird bought 25,424 Amgen shares in Q1 2015, an estimated $4M.
- Amgen made up 0.19% of Baird's portfolio in Q1 2015, its #159 holding.
- Baird first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
- 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.
Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.